Association study of functional genetic variants of innate immunity related genes in celiac disease

BMC Medical Genetics

Volumn 6, Issue , 2005, Pages

  Rueda, B ^a   Zhernakova, A ^b   López Nevot, Miguel A ^c   Martin J ^a   Koeleman, B P C ^b  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; INTERLEUKIN 1;

ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; FAMILY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROMOTER REGION; STATISTICAL SIGNIFICANCE; GENE; GENETICS; INNATE IMMUNITY; MULTIGENE FAMILY; PHYSIOLOGY;

CELIAC DISEASE; CHEMOKINE CCL2; CHEMOKINE CCL5; CHILD; FEMALE; GENES; GENETIC VARIATION; GENOTYPE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1; INTERLEUKIN-18; MALE; MULTIGENE FAMILY;

EID: 26444480305     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-6-29     Document Type: Article

References (48)

1. Sollid LM: Coeliac disease: dissecting a complex inflammatory disorder. Nature Review Immunology 2002, 2:647.
2. Louka AS, Sollid LM: HLA in coeliac disease: Unravelling the complex genetics of a complex disorder. Tissue Antigens 2003, 61:105-117.
3. Green PH, Jabri B: Coeliac disease. Lancet 2003, 362:383-391.
4. Schuppan D, Esslinger B, Dieterich W: Innate immunity and coeliac disease. Lancet 2003, 362:3-4.
5. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M: Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362:30-37.
6. Tuckova L, Novotna J, Novak P, Flegelova Z, Kveton T, Jelinkova L, Zidek Z, Man P, Tlaskalova-Hogenova H: Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol 2002, 71:625-631.
7. Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O, Hammarstrom ML: Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 2004, 99:894-904.
8. Chowers Y, Marsh MN, De Grandpre L, Nyberg A, Theofilopoulos AN, Kagnoff MF: Increased proinflammatory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge. Clin Exp Immunol 1997, 107:141-147.
9. Fornari MC, Pedreira S, Niveloni S, Gonzalez D, Diez RA, Vazquez H, Mazure R, Sugai E, Smecuol E, Boerr L, et al.: Pre- and post-treatment serum levels of cytokines 1L-1beta, 1L-6, and 1L-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 1998, 93:413-418.
10. Salvati VM, MacDonald TT, Bajaj-Elliott M, Borrelli M, Staiano A, Auricchio S, Troncone R, Monteleone G: Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002, 50:186-190.
11. Arend WP: The balance between 1L-1 and 1L-1Ra in disease. Cytokine Growth Factor Rev 2002, 13:323-340.
12. di Giovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1 beta gene (1L1 beta). Hum Mol Genet 1992, 1:450.
13. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW: A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995, 38:221-228.
14. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB: Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004, 50:1976-1983.
15. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW: Polymorphism in human 1L-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993, 91:403-404.
16. Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002, 34:204-209.
17. Gracie JA, Robertson SE, McInnes IB: Interleukin-18. J Leukoc Biol 2003, 73:213-224.
18. Eaton AD, Xu D, Garside P: Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology 2003, 108:196-203.
19. Lettesjo H, Hansson T, Bergqvist A, Gronlund J, Dannaeus A: Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease. Clin Exp Immunol 2005, 139:138-143.
20. Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H: Regulation of 1L-18 (IFN-gamma-inducing factor) gene expression. J Immunol 1997, 159:6156-6163.
21. Giedraitis V, He B, Huang WX, Hillert J: Cloning and mutation analysis of the human 1L-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001, 112:146-152.
22. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, et al.: Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 1999, 96:4581-4585.
23. McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH, et al.: Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. Aids 2000, 14:2671-2678.
24. Rovin BH, Lu L, Saxena R: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999, 259:344-348.
25. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990, 65:909-11.
26. Craggs A, West S, Curtis A, Welfare M, Hudson M, Donaldson P, Mansfield J: Absence of a genetic association between 1L-1RN and 1L-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England. Scand J Gastroenterol 2001, 36:1173-1178.
27. Dudbridge F: Methods and software for association tests of uncertain haplotypes in case-parent trios. Am J Hum Genet 2002, 71(SupplA2338 [http://portal.litbio.org/Registered/Webapp/glue/].
28. Gauderman WJ: Candidate gene association analysis for a quantitative trait, using parent-offspring trios. Genet Epidemiol 2003, 25:327-338.
29. al Sharif F, Ollier WE, Hajeer AH: A rare polymorphism at position -28 in the human RANTES promoter. Eur J Immunogenet 1999, 26:373-374.
30. Hajeer AH, al Sharif F, Ollier WE: A polymorphism at position - 403 in the human RANTES promoter. Eur J Immunogenet 1999, 26:375-376.
31. Parks CG, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP: Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004, 63:91-94.
32. Timms AE, Crane AM, Sims AM, Cordell HJ, Bradbury LA, Abbott A, Coyne MR, Beynon O, Herzberg I, Duff GW, et al.: The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004, 75:587-595.
33. Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, Ko Ko C, Jones PW, Fryer AA, Strange RC, Thompson AJ, et al.: Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol 2002, 129:197-204.
34. Kaijzel EL, van Dongen H, Bakker AM, Breedveld FC, Huizinga TW, Verweij CL: Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis. Tissue Antigens 2002, 59:122-126.
35. Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, Takahashi R, Kuwahara H, Fujita N, Kita A, et al.: Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease. Ann N Y Acad Sci 2003, 1005:436-439.
36. Novota P, Kolostova K, Pinterova D, Novak J, Treslova L, Andel M, Cerna M: Interleukin 1L-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett 2005, 96:247-251.
37. Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T, et al.: RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 2003, 26:892-898.
38. Liao CH, Yao TC, Chung HT, See LC, Kuo ML, Huang JL: Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 2004, 31:2062-2067.
39. Tucci M, Barnes EV, Sobel ES, Croker BP, Segal MS, Reeves WH, Richards HB: Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004, 50:1842-1849.
40. Kim HL, Lee DS, Yang SH, Lim CS, Chung JH, Kim S, Lee JS, Kim YS: The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 2002, 40:1146-1152.
41. Gade-Andavolu R, Comings DE, MacMurray J, Vuthoori RK, Tourtellotte WW, Nagra RM, Cone LA: RANTES: a genetic risk marker for multiple sclerosis. Mult Scler 2004, 10:536-539.
42. Makki RF, al Sharif F, Gonzalez-Gay MA, Garcia-Porrua C, Ollier WE, Hajeer AH: RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 2000, 18:391-393.
43. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P: Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
44. Rueda B, Martinez A, Lopez-Nevot MA, Mas-Fontao A, Paco L, Ortega E, Fernandez-Arquero M, Urcelay E, Gomez de la Concha E, Martin J: A functional variant of IFNgamma gene is associated with coeliac disease. Genes Immun 2004, 5:517-519.
45. Louka AS, Torinsson Naluai A, D'Alfonso S, Ascher H, Coto I, Ek J, Giordano M, Gudjonsdottir AH, Mellai M, Momigliano-Richiardi P, et al.: The 1L12B gene does not confer susceptibility to coeliac disease. Tissue Antigens 2002, 59:70-72.
46. Seegers D, Borm ME, van Belzen MJ, Mulder CJ, Bailing J, Crusius JB, Meijer JW, Wijmenga C, Pena AS, Bouma G: 1L12B and IRF1 gene polymorphisms and susceptibility to celiac disease. Eur J Immunogenet 2003, 30:421-425.
47. de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA: Celiac disease and TNF promoter polymorphisms. Hum Immunol 2000, 61:513-517.
48. Woolley N, Mustalahti K, Maki M, Partanen J: Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population. Scand J Immunol 2005, 61:51-56.